EP0480918A4 - Analogues de l'hormone de liberation de l'hormone de luteinisation a taille reduite. - Google Patents

Analogues de l'hormone de liberation de l'hormone de luteinisation a taille reduite.

Info

Publication number
EP0480918A4
EP0480918A4 EP19890902991 EP89902991A EP0480918A4 EP 0480918 A4 EP0480918 A4 EP 0480918A4 EP 19890902991 EP19890902991 EP 19890902991 EP 89902991 A EP89902991 A EP 89902991A EP 0480918 A4 EP0480918 A4 EP 0480918A4
Authority
EP
European Patent Office
Prior art keywords
reduced size
lhrh analogs
lhrh
analogs
size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19890902991
Other languages
German (de)
English (en)
Other versions
EP0480918A1 (fr
Inventor
Fortuna Haviv
Jonathan Greer
Christopher A Palabrica
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of EP0480918A4 publication Critical patent/EP0480918A4/fr
Publication of EP0480918A1 publication Critical patent/EP0480918A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP89902991A 1988-02-10 1989-02-09 Analogues de l'hormone de liberation de l'hormone de luteinisation a taille reduite Withdrawn EP0480918A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15468288A 1988-02-10 1988-02-10
US154682 1988-02-10

Publications (2)

Publication Number Publication Date
EP0480918A4 true EP0480918A4 (fr) 1991-06-04
EP0480918A1 EP0480918A1 (fr) 1992-04-22

Family

ID=22552315

Family Applications (2)

Application Number Title Priority Date Filing Date
EP89902991A Withdrawn EP0480918A1 (fr) 1988-02-10 1989-02-09 Analogues de l'hormone de liberation de l'hormone de luteinisation a taille reduite
EP19890102207 Pending EP0328089A3 (fr) 1988-02-10 1989-02-09 Analogues des LHRH à dimension réduite

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP19890102207 Pending EP0328089A3 (fr) 1988-02-10 1989-02-09 Analogues des LHRH à dimension réduite

Country Status (4)

Country Link
EP (2) EP0480918A1 (fr)
JP (1) JP2673025B2 (fr)
CA (1) CA1339679C (fr)
WO (1) WO1989007451A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68928278T2 (de) * 1988-02-10 1998-03-12 Tap Pharmaceuticals Inc Lhrh-analog
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
EP1297850B1 (fr) 2000-07-05 2015-08-19 Takeda Pharmaceutical Company Limited Preparations medicinales pour le traitement des maladies dependant des hormones sexuelles
TWI225416B (en) 2001-06-29 2004-12-21 Takeda Chemical Industries Ltd Sustained-release composition and process for producing the same
CA2466659A1 (fr) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Agents anticancer
AU2004232314B2 (en) 2003-04-22 2007-11-22 Ipsen Pharma S.A.S. Peptide vectors
US9517210B2 (en) 2012-07-12 2016-12-13 Takeda Pharmaceutical Company Limited Method for producing microcapsule powder

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087419A (en) * 1976-11-05 1978-05-02 Parke, Davis & Company Heptapeptides and methods for their production
EP0041286A1 (fr) * 1980-06-02 1981-12-09 Andrew Victor Schally Antagonistes de la LH-RH
EP0162575A2 (fr) * 1984-05-21 1985-11-27 The Salk Institute For Biological Studies Antagonistes GNRH VII

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4010125A (en) 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4493934A (en) 1979-10-01 1985-01-15 Merck & Co., Inc. 2(3-Amino-2-oxopyrrolidin-1-yl) acetic acid and n-acylated derivatives thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087419A (en) * 1976-11-05 1978-05-02 Parke, Davis & Company Heptapeptides and methods for their production
EP0041286A1 (fr) * 1980-06-02 1981-12-09 Andrew Victor Schally Antagonistes de la LH-RH
EP0162575A2 (fr) * 1984-05-21 1985-11-27 The Salk Institute For Biological Studies Antagonistes GNRH VII

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8907451A1 *

Also Published As

Publication number Publication date
EP0328089A3 (fr) 1990-11-28
EP0328089A2 (fr) 1989-08-16
CA1339679C (fr) 1998-02-17
EP0480918A1 (fr) 1992-04-22
JP2673025B2 (ja) 1997-11-05
JPH03503165A (ja) 1991-07-18
WO1989007451A1 (fr) 1989-08-24

Similar Documents

Publication Publication Date Title
EP0417454A3 (en) Reduced size lhrh analogs
IL95136A0 (en) Lhrh analogs
DE58901334D1 (en) Difluorbenzolderivate.
DE58900568D1 (en) Duennschichtsolarzellenanordnung.
DE68911805D1 (en) Phasenrauschmesseinrichtung.
DE58904529D1 (en) Thermostatisiergeraet.
DE68909054D1 (en) Hüftgelenkprothese.
DE68905877D1 (en) Tuerspiegelaufbau.
DE68901042D1 (en) Phosphitamin-schmieroeladditive.
DE68907379D1 (en) Waeschetrockner.
DE58902248D1 (en) Buegeleisensohle.
DE58903464D1 (en) Chemosensitiver wandler.
DE68908284D1 (en) Muenzausgabevorrichtung.
DE68902332D1 (en) Oelabscheider.
DE58905558D1 (en) Whirlpool-düse.
DE58904098D1 (en) N-aryltetrahydrophthalimidverbindungen.
EP0400065A4 (en) Lhrh analogs
DE58902743D1 (en) Substituierte n-aryl-stickstoffheterocyclen.
DE68907450D1 (en) Tuersteuerungsvorrichtung.
DE58904923D1 (en) Fluegelzellenverdichter.
DE68908328D1 (en) Wuerfelschneidvorrichtung.
DE68900005D1 (en) Tank-container.
EP0480918A4 (fr) Analogues de l'hormone de liberation de l'hormone de luteinisation a taille reduite.
DE58902926D1 (en) Isothiazolazofarbstoffe.
DE68906693D1 (en) Fluegelzellenpumpe.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19900712

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE FR GB IT LI NL SE

XX Miscellaneous

Free format text: VERBUNDEN MIT 89102207.1/0328089 (EUROPAEISCHE ANMELDENUMMER/VEROEFFENTLICHUNGSNUMMER) DURCH ENTSCHEIDUNG VOM 03.11.93.

17Q First examination report despatched

Effective date: 19931115

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19970902

RBV Designated contracting states (corrected)

Designated state(s): BE CH DE ES FR GB GR IT LI NL SE